1. Home
  2. RENB vs EEA Comparison

RENB vs EEA Comparison

Compare RENB & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENB
  • EEA
  • Stock Information
  • Founded
  • RENB 2011
  • EEA 1986
  • Country
  • RENB United States
  • EEA Germany
  • Employees
  • RENB N/A
  • EEA N/A
  • Industry
  • RENB Biotechnology: Pharmaceutical Preparations
  • EEA Trusts Except Educational Religious and Charitable
  • Sector
  • RENB Health Care
  • EEA Finance
  • Exchange
  • RENB Nasdaq
  • EEA Nasdaq
  • Market Cap
  • RENB 57.7M
  • EEA 67.9M
  • IPO Year
  • RENB N/A
  • EEA N/A
  • Fundamental
  • Price
  • RENB $0.26
  • EEA $10.62
  • Analyst Decision
  • RENB
  • EEA
  • Analyst Count
  • RENB 0
  • EEA 0
  • Target Price
  • RENB N/A
  • EEA N/A
  • AVG Volume (30 Days)
  • RENB 866.4K
  • EEA 9.2K
  • Earning Date
  • RENB 10-09-2025
  • EEA 01-01-0001
  • Dividend Yield
  • RENB N/A
  • EEA 1.92%
  • EPS Growth
  • RENB N/A
  • EEA N/A
  • EPS
  • RENB N/A
  • EEA N/A
  • Revenue
  • RENB N/A
  • EEA N/A
  • Revenue This Year
  • RENB N/A
  • EEA N/A
  • Revenue Next Year
  • RENB N/A
  • EEA N/A
  • P/E Ratio
  • RENB N/A
  • EEA N/A
  • Revenue Growth
  • RENB N/A
  • EEA N/A
  • 52 Week Low
  • RENB $0.22
  • EEA $7.45
  • 52 Week High
  • RENB $2.10
  • EEA $9.26
  • Technical
  • Relative Strength Index (RSI)
  • RENB 51.07
  • EEA 57.98
  • Support Level
  • RENB $0.22
  • EEA $10.41
  • Resistance Level
  • RENB $0.25
  • EEA $10.82
  • Average True Range (ATR)
  • RENB 0.02
  • EEA 0.19
  • MACD
  • RENB 0.00
  • EEA 0.00
  • Stochastic Oscillator
  • RENB 84.44
  • EEA 71.43

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

Share on Social Networks: